New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 2, 1998, Pages 189-194

  Ojima, Iwao ^a   Bounaud, Pierre Yves ^a   Takeuchi, Craig ^a   Pera, Paula ^b   Bernacki, Ralph J ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; GLYCOPROTEIN P; PACLITAXEL; TAXANE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER CELL; CHEMICAL MODIFICATION; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MODULATION; MULTIDRUG RESISTANCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; HUMANS; P-GLYCOPROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; TAXOIDS; TRITERPENES; TUMOR CELLS, CULTURED;

EID: 0032548461     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10218-9     Document Type: Article

References (15)

1. 1. (a) Ford, J. M.; Hait, W. N. Pharmacol. Rev. 1990, 42, 155;
2. (b) Gottesman, M. M.; Pastan, I. Annu. Biochem. 1993, 62, 385.
3. 2. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1981, 41, 1967.
4. 3. (a) Chauffert, B.; Martin, M.; Hammann, A.; Michel, M.-F.; Martin, F. Cancer Res. 1986, 46, 825;
5. (b) Pearce, H. L.; Safa, A. R.; Bach, N. J.; Winter, M. A.; Cirtain, M. C.; Beck, W. T. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5128;
6. (c) Ford, J. M.; Prozialeck, W. C.; Hait, W. N. Mol. Pharmacol. 1989, 35, 105;
7. (d) Twentyman, P. R. Br. J. Cancer 1988, 57, 254;
8. (e) Naito, M.; Oh-hara, T.; Yamazaki, A.; Danki, T.; Tsuruo, T. Cancer Chemother Pharmacol. 1992, 29, 195.
9. 4. (a) Kobayashi, J.; Ogiwara, A.; Hosoyama, H.; Shigemori, H.; Yoshida, N.; Sasaki, T.; Li, Y.; Iwasaki, S.; Naito, M.; Tsuruo, T. Tetrahedron 1994, 50, 7401;
10. (b) Kobayashi, J.; Hosoyama, H.; Wang, X.-X.; Shigemori, H.; Koiso, Y.; Iwasaki, S.; Sasaki, T.; Naito, M.; Tsuruo, T. Bioorg. Med. Chem. Lett. 1997, 7, 393.
11. 5. (a) Denis, J.-N.; Greene, A. E.; Guénard, D.; Guéritte-Voegelein, F.; Mangatal, L.; Potier, P. J. Am. Chem. Soc. 1988, 110, 5917;
12. (b) Kant, J.; O'Keeffe, W. S.; Chen, S.-H.; Farina, V.; Fairchild, C; Johnston, K.; Kadow, J. F.; Long, B. H.; Vyas, D. A. Tetrahedron Lett. 1994, 35, 5543;
13. (c) Nicolaou, K. C.; Renaud, J.; Nanternet, P. G.; Couladouros, E. A.; Guy, R. K.; Wrasidlo, W. J. Am. Chem. Soc. 1995, 117, 2409.
14. 2-OH). Taxane 6 was obtained through the hydrogenation (500 psi) of taxane 2 or 3 over 5% Rh/C.
15. 7. Ojima, I.; Duclos, O.; Dormán, G.; Simonot, B.; Prestwich, G. D.; Rao, S.; Lerro, K. A.; Horwitz, S. B. J. Med. Chem. 1995, 38, 3891.